Tadej Avcin retweeted
In Ljubljana 🇸🇮 attending the @ern_reconnet #Transition training workshop! Looking forward to 2 days of exchanges and brainstorming together. Thank you to @TadejAvcin and Mojca Zajc for the invitation 😊
Tadej Avcin retweeted
📢 PReS is now on social media!
Follow us and be the first to know about our initiatives and ongoing activities!
Let’s grow and strengthen our community together.
#PReS #PaediatricRheumatology #StayConnected
Tadej Avcin retweeted
📢Exciting news! Our paper on core & expanded datasets for cSLE research is out @ARD_BMJ! 🌍 Huge global collaboration supported by @carrainc & PReS/@PReSLupusWP. ⏲️Time to start collecting these data to collaborate & make a difference worldwide! 🤝 ard.bmj.com/cgi/rapidpdf/ard….
Selfi photo of a wonderful group of the EU Interreg project #CONCERTO🤝🙏🇮🇹🇸🇮
Tadej Avcin retweeted
20.09.24 - 11 a.m @ Faculty of Medicine, University of Ljubljana
🇮🇹 si terrà il meeting annuale del progetto CONCERTO.
🇸🇮 potekalo letno srečanje projekta CONCERTO.
🇬🇧 the annual meeting of the CONCERTO project will be held.
#InterregITASLO @InterregITASLO #Interregitasloconcerto
Tadej Avcin retweeted
🇮🇹 Ecco il programma del meeting annuale che si terrà il 20.09: ita-slo.eu/it/notizie-ed-eve…
🇸🇮 Tukaj je program letnega srečanja, ki bo potekalo 20.09: ita-slo.eu/sl/novice-in-dogo…
🇬🇧Here is the programme for the annual meeting to be held on 20.09: ita-slo.eu/en/news-and-event…
#InterregITASLO
Congratulations to all the winners of the best abstracts award at the #PReS2024 Young Investigators Meeting
Very pleased to announce launching of PReS and Neutrolis partnership in developing target therapy in patients w/ DNASE1L3 def. Please register if interested neutrolis.com/patients
Tadej Avcin retweeted
NEW SERIES on #pregnancy in rheumatic disease calls for a reconsideration of therapeutic decisions to optimise the safe and effective use of DMARDs, and proposes solutions to the challenges of studies in pregnancy
thelancet.com/series/pregnan… #EULAR2024
Tadej Avcin retweeted
🌟 B-cell depletion in autoimmune diseases
🔷 Review
🔷Current therapeutic strategies to deplete B cells in order to ameliorate or potentially even cure autoimmune disease
🔗 bit.ly/3RwAWBx
Serum TNF-alpha levels do not correlate with JIA disease activity in patients treated with TNF inhibitors. These drugs extend TNF-alpha half-life and serum levels of TNF-alpha do not reflect inflammatory activity in the joints rdcu.be/dIJ33
Thank you @AlexandreBelot for outstanding grand round and stimulating research discussions during the visiting professorship at the Univ. Children's Hospital Ljubljana 🇨🇵🇸🇮👏🤝
Proud of my colleague Natasa Toplak showing safety data of prospective MMR/MMRV vaccine booster study in patients on biologics #Autoimmunity2024
The CABC conference is also and exemplary model of collaboration between patients and physicians. Hearing and learning from touching testimonials from patients and parents🙏
Amazing program and stimulating discussions at the UCAN Childhood arthritis & beyond conference in Toronto🇨🇦 🇳🇱 We are slowly getting closer to the biology based taxonomy of JIA. Very pleased to be invited and meeting old and new friends from SickKids!
Please check the new HORIZON-MSCA PhD Position in Immunology at the UCH Ljubljana focusing on genomics and single-cell transcriptomics in JIA 👉euraxess.ec.europa.eu/jobs/2…
Deadline to apply 8th May 2024
Tadej Avcin retweeted
✅ Who coming to the 14th international congress of #autoimmunity? (17-20 May 2024 in Ljubljana, Slovenia) I'm invited to talk about the complexity of #patient pathways in #autoimmune diseases such as #lupus. So many unmet need and disruption points
LINK: doi.org/10.1136/lupus-2022-0…


























